In a recent webinar hosted by Roche Diagnostics Asia Pacific, Dr James Ho, a Clinical Associate Professor in the Department of Medicine at the University of Hong Kong, shared insights on the current state of lung cancer diagnostics and how COVID-19 is impacting patient care. The webinar begins with an overview of the key diagnostic tools […]
Lung cancer diagnostics in the COVID-19 era: insights from Dr James Ho Read More »
In the ongoing fight against the COVID-19 pandemic, many healthcare systems are adding interleukin-6 (IL-6) to their diagnostic toolkit. An early predictor of severe COVID-19, IL-6 is an ideal prognostic biomarker because it can be detected from an easily accessible biological source (serum or plasma) and via well-characterised, rapid assay systems. A growing body of
IL-6 shows promise for COVID-19 management in Asia Pacific Read More »
As Director of the Point-of-Care Testing Center for Teaching and Research (POCT•CTR) and Professor Emeritus of Pathology and Laboratory Medicine at the University of California Davis School of Medicine, Dr Gerald Kost is one of the world’s leading experts in point-of-care testing (POCT). He is also a Fulbright Scholar 2020-21 in ASEAN. In this Q&A,
Point-of-care testing for pandemic management: an interview with Dr Gerald Kost Read More »
As one of India’s leading private hospitals, P.D. Hinduja Hospital & Medical Research Centre provides premium service that focuses heavily on patient experience. Based in Mumbai, the multi-specialty hospital has a strong reputation in a market where demand for high-quality healthcare services is rising rapidly. The Lab Insights team recently spoke with Mr. Joy Chakraborty,
Patient centricity in a pandemic: a case study from P.D. Hinduja Hospital in India Read More »
As founder and group CEO of Pathology Asia Holdings (PAH), Dr Christopher Ting manages one of Southeast Asia’s leading clinical laboratory networks. With operations in Singapore, Malaysia, Vietnam and Australia, his company is playing an important role in the regional fight against the COVID-19 pandemic. He is also launching initiatives and making investments to ensure its
CEO Viewpoint: Dr Chris Ting on lab leadership in the COVID-19 era Read More »
In a climate of widespread uncertainty about COVID-19 and rapidly changing guidelines for diagnosing and treating the disease, many healthcare professionals struggle to explain the test results and treatment plans to patients. The challenge is especially acute in multicultural societies like Singapore with large communities of foreign migrant workers. To help overcome these challenges, a team of
COVID Buddy app brings better care to Singapore’s migrant workers Read More »
Amid the ongoing COVID-19 pandemic, digital pathology technologies are being used in new ways and helping to ensure continuity of care despite widespread lockdowns, travel restrictions and social distancing measures. Three exciting use cases were presented in recent webinar hosted by Roche Diagnostics Asia Pacific, with experts from Australia, India, Myanmar and Thailand sharing their
COVID-19 accelerates digital pathology innovation Read More »
On 23 Jun 2020, Roche Diagnostics Asia Pacific hosted a webinar on recent trends in digital pathology adoption and usage during the COVID-19 pandemic. The webinar featured five leading pathology experts from across the region: Dr Pairoj Junyangdikul – Deputy Managing Director of N-Health Pathology Thailand Laboratory Dr Myat Wai Hsu – Consultant Pathologist, N
Digital pathology in the COVID-19 era (webinar) Read More »
Among the many stakeholders who are responsible for developing and implementing a national strategy for COVID-19 testing, government policymakers play a unique and important role. In addition to managing regulatory processes, they also have a strong influence over setting testing criteria and establishing the infrastructure necessary to handle rapid surges in demand. While new testing
COVID-19 testing in Asia: how government policy shapes access to PCR diagnostics Read More »
As the Head and Consultant at the Molecular Diagnosis Centre (MDC) at National University Hospital (NUH), a major tertiary medical institution in Singapore’s public health system, Dr Benedict Yan plays a critical role in his country’s response to the COVID-19 pandemic. In a webinar on 24 Apr 2020, he shared key updates on his experience with an audience
COVID-19 testing in Singapore: key updates from a public hospital lab Read More »
Subscribe to Lab Insights latest news and update
Join over 3,000 HCPs receiving insights in their inbox.
